UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Terminated
Unique ID issued by UMIN UMIN000027389
Receipt No. R000031281
Scientific Title Clinical trial of S-1 plus intravenous and intraperitoneal paclitaxel for gastric cancer with peritoneal metastasis or positive peritoneal cytology
Date of disclosure of the study information 2017/05/19
Last modified on 2019/06/06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Clinical trial of S-1 plus intravenous and intraperitoneal paclitaxel for gastric cancer with peritoneal metastasis or positive peritoneal cytology
Acronym Clinical trial of S-1 plus intravenous and intraperitoneal paclitaxel for gastric cancer with peritoneal metastasis or positive peritoneal cytology
Scientific Title Clinical trial of S-1 plus intravenous and intraperitoneal paclitaxel for gastric cancer with peritoneal metastasis or positive peritoneal cytology
Scientific Title:Acronym Clinical trial of S-1 plus intravenous and intraperitoneal paclitaxel for gastric cancer with peritoneal metastasis or positive peritoneal cytology
Region
Japan

Condition
Condition Gastric cancer with peritoneal metastasis or positive peritoneal cytology.
Classification by specialty
Gastrointestinal surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the safety and efficacy of S-1 plus intravenous and intraperitoneal paclitaxel for gastric cancer with peritoneal metastasis or positive peritoneal cytology
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Safety
Key secondary outcomes Disease control rate.
three year overall survival.
Progression free survival.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 S-1 was administered orally at a dose 80mg/m2/day for 14 consecutive days, followed by 7days of rest. PTX was administered intravenou at a dose of 50mg/m2 and intraperitoneal at a dose of 20mg/m2 on days 1 and 8.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
85 years-old >
Gender Male and Female
Key inclusion criteria 1) histologically proven primar gastric adenocarcinoma.
2) Peritneal metastasis and/or cancer cells on peritoneal cytology.
3) Adequate function of important organs (witin 14 days before registration).
Neutrocyte >= 1,000/mm3
Hemoglobin >= 8.0g/dl
Platelet >= 75,000/mm3
serum transaminases < 100U/L
Total Bilirubin <= 3.0mg/dL
Creatinine clearance >= 30ml/min
4) Eastern Cooperative Oncology Group performance status 0-2
5) Age >= 20, < 85 years
6) Written informed consent.
Key exclusion criteria 1)The absence of metastasis to distant organ sites except the retroperitoneum, ovary and abdominal lymph nodes.
2)Contraindication to S-1 or paclitaxel.
3)Apparent infection or inflammation.
4)Sever heart disease.
5)Sever complication.
6)Gastrointestinal bleeding requiring blood transfusion repeatedly.
7)Pregnancy, breast feeding or intention to become pregnant.
8)Judeged inappropriate for this trial for other reasons.
Target sample size 15

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Hirohiko Kuroda
Organization Tottori University School of Medicine
Division name Division of Surgical Oncology
Zip code
Address 36-1 Nishi-cho, Yonago, Tottori
TEL 0859-38-6567
Email kuroda-ttr@umin.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Hirohiko Kuroda
Organization Tottori University School of Medicine
Division name Division of Surgical Oncology
Zip code
Address 36-1 Nishi-cho, Yonago, Tottori
TEL 0859-38-6567
Homepage URL
Email kuroda-ttr@umin.ac.jp

Sponsor
Institute Tottori University Hospital
Institute
Department

Funding Source
Organization Tottori University Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 05 Month 19 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Terminated
Date of protocol fixation
2017 Year 05 Month 01 Day
Date of IRB
2017 Year 05 Month 01 Day
Anticipated trial start date
2017 Year 05 Month 19 Day
Last follow-up date
2022 Year 05 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2017 Year 05 Month 18 Day
Last modified on
2019 Year 06 Month 06 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031281

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.